Common use of Internal Controls and Compliance with the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act Clause in Contracts

Internal Controls and Compliance with the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act. The Company and its boards of directors are in compliance with ▇▇▇▇▇▇▇▇-▇▇▇▇▇ and all applicable Exchange Rules. Except as set forth in the General Disclosure Package, the Company maintains a system of internal controls, including, but not limited to, internal controls over accounting matters and financial reporting and legal and regulatory compliance controls (collectively, “Internal Controls”) that comply with the Securities Laws and are sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles and to maintain accountability for assets, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Internal Controls are overseen by the audit committee of the Company’s board of directors in accordance with Exchange Rules. The Company has not publicly disclosed or reported to the audit committee or its board of directors, and within the next 90 days the Company does not reasonably expect to publicly disclose or report to its audit committee or its board of directors, material weakness (including significant deficiencies that, when aggregated, raise to the level of a material weakness), change in Internal Controls or fraud involving management or other employees who have a significant role in Internal Controls, any violation of, or failure to comply with, the Securities Laws, or any matter which, if determined adversely, would have a Material Adverse Effect.

Internal Controls and Compliance with the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act. The Company and its boards of directors are is in compliance in all material respects with the applicable provisions of ▇▇▇▇▇▇▇▇-▇▇▇▇▇ and all applicable Exchange Rules. Except as set forth in the General Disclosure Package, the The Company maintains a system of internal controls, including, but not limited toincluding disclosure controls and procedures, internal controls over accounting matters and financial reporting and legal and regulatory compliance controls (collectively, “Internal Controls”) that comply with the applicable Securities Laws and are sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizationsauthorization, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. Generally Accepted International Financial Reporting Standards as issued by the International Accounting Principles Standards Board (“IFRS”) and to maintain accountability for assets, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Internal Controls are are, or upon consummation of the offering of the Offered Securities will be, overseen by the audit committee of the Company’s board of directors Audit Committee in accordance with applicable Exchange Rules. The Company has not publicly disclosed or reported to the audit committee Audit Committee or its board of directorsthe Board, and within the next 90 135 days the Company does not reasonably expect to publicly disclose or report to its audit committee the Audit Committee or its board of directorsthe Board, material weakness (including a significant deficiencies thatdeficiency, when aggregated, raise to the level of a material weakness), change in Internal Controls or fraud involving management or other employees who have a significant role in Internal Controls, any violation of, or failure to comply with, the Securities Laws, or any matter which, if determined adversely, would have a Material Adverse Effect.

Internal Controls and Compliance with the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act. The Except as set forth in the General Disclosure Package, the Company and its boards of directors subsidiaries are in compliance in all material respects with ▇▇▇▇▇▇▇▇-▇▇▇▇▇ and all applicable Exchange Rules. Except as set forth in the General Disclosure Package, the The Company maintains a system of internal controls, including, but not limited to, disclosure controls and procedures, internal controls over accounting matters and financial reporting reporting, an internal audit function and legal and regulatory compliance controls (collectively, “Internal Controls”) that comply with the Securities Laws and are sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles GAAP and to maintain accountability for assets, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Internal Controls are overseen by the audit committee Audit Committee (the “Audit Committee”) of the Company’s board of directors Board in accordance with Exchange Rules. The Company has not publicly disclosed or reported to the audit committee Audit Committee or its board of directorsthe Board, and within prior to the next 90 days filing of or in the Company’s 2012 Annual Report on Form 10-K the Company does not reasonably expect to publicly disclose or report to its audit committee the Audit Committee or its board of directorsthe Board, material weakness (including significant deficiencies that, when aggregated, raise to the level of a material weakness), change in Internal Controls or fraud involving management or other employees who have a significant role in Internal ControlsControls (each, an “Internal Control Event”), any violation of, or failure to comply with, the Securities Laws, or any matter which, if determined adversely, would have a Material Adverse Effect.

Internal Controls and Compliance with the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act. The Company and its boards of directors are is in compliance with ▇▇▇▇▇▇▇▇-▇▇▇▇▇ ▇, to the extent applicable to the Company, and all applicable Exchange Rules. Except as set forth in the General Disclosure Package, the The Company maintains a system of internal controls, including, but not limited to, disclosure controls and procedures, internal controls over accounting matters and financial reporting reporting, an internal audit function and legal and regulatory compliance controls (collectively, “Internal Controls”) that comply with the Securities Laws and are sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. Generally General Accepted Accounting Principles and to maintain accountability for assets, (iii) access to assets is permitted only in accordance with management’s general or specific authorization authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Internal Controls are overseen by the audit committee Audit Committee (the “Audit Committee”) of the Company’s board of directors Board in accordance with the Exchange Rules. The Company has not publicly disclosed or reported to the audit committee or its board of directorsdisclosed, and within the next 90 days the Company does not reasonably expect to publicly disclose or report to its audit committee the Audit Committee or its board of directorsthe Board, a significant deficiency, material weakness (including significant deficiencies that, when aggregated, raise to the level of a material weakness), change in Internal Controls or fraud involving management or other employees who have a significant role in Internal ControlsControls (each, an “Internal Control Event”), any violation of, or failure to comply with, the Securities Laws, or any matter which, if determined adversely, would have a Material Adverse Effect.

Internal Controls and Compliance with the ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act. The Company Except as set forth in the General Disclosure Package, the Company, its subsidiaries and its boards the Company’s Board of directors Directors (the “Board”) are in compliance with all applicable provisions of ▇▇▇▇▇▇▇▇-▇▇▇▇▇ and all applicable Exchange Rules. Except as set forth in the General Disclosure Package, the The Company maintains a system of internal controls, including, but not limited to, disclosure controls and procedures, internal controls over accounting matters and financial reporting reporting, an internal audit function and legal and regulatory compliance controls (collectively, “Internal Controls”) that comply with the Securities Laws and are sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorizationsauthorization of management and directors, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. Generally General Accepted Accounting Principles and to maintain accountability for assets, (iii) access to assets is permitted only records are maintained that, in accordance with managementreasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s general or specific authorization assets, and (iv) unauthorized acquisitions, use or dispositions of the recorded accountability for Company’s assets is compared with that could have a material effect on the existing assets at reasonable intervals and appropriate action is taken with respect to any differencesconsolidated financial statements are prevented or timely detected. The Internal Controls are are, or upon consummation of the offering of the Offered Securities will be, overseen by the audit committee Audit Committee (the “Audit Committee”) of the Company’s board of directors Board in accordance with Exchange Rules. The Company has not publicly disclosed or reported to the audit committee Audit Committee or its board of directorsthe Board, and within the next 90 135 days the Company does not reasonably expect to publicly disclose or report to its audit committee the Audit Committee or its board of directorsthe Board, a significant deficiency, material weakness (including significant deficiencies that, when aggregated, raise to the level of a material weakness), change in Internal Controls or fraud involving management or other employees who have a significant role in Internal ControlsControls (each, an “Internal Control Event”), any violation of, or failure to comply with, the Securities Laws, or any matter which, if determined adversely, would have a Material Adverse Effect.